Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal ...

A small cluster of damaged immune cells can do outsized harm. That is the picture emerging from new research at UCLA, where ...

Nearly two billion people could have fatty liver disease by 2050, marking a silent global health crisis linked to rising ...

Evelyn Rivera had never heard of hepatitis C — until she was diagnosed with it. In 1995, Rivera, then a single mom to a couple small kids, participated in an elementary school blood drive. A few ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults around the globe. It starts when fat builds up inside the liver’s cells. Over time, this buildup can ...

I stared at the MRI scan on my computer screen with a mixture of alarm and disbelief. The large pink swathes coating my ...

There is considerable evidence that microplastics and nanoplastics are present in the livers of humans, and wild animal ...

A newly identified population of dysfunctional immune cells may play a central role in both aging and chronic disease.

The liver is one of the hardest-working organs in the human body. It detoxifies harmful substances, helps with digestion, stores nutrients, and regulates metabolism. Despite its remarkable resilience ...

April is Alcohol Awareness Month, and liver disease may be on the rise. New evidence suggests alcohol related liver disease ...

Discover a promising new treatment for MASLD. A recent study shows how a combination of two existing drugs, pemafibrate and ...

The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...